CITRIS and the Banatao Institute
Creating information technology solutions for society's most pressing challenges
Subscribe to our mailing list and get the latest CITRIS news, research updates and event announcements delivered straight to your inbox.
CITRIS Executive Director Camille Crittenden was featured in the UC IT Blog’s Q&A series and spoke about the need for women in technology, her work […]
Institute responds to coronavirus crisis We find ourselves in extraordinary times. As our research community faces the coronavirus pandemic, our thoughts turn to what contributions we […]
CITRIS Foundry alum Aluna recently received clearance from the U.S. Food and Drug Administration (FDA) for its asthma management device and platform. Aluna helps patients, particularly pediatric patients, […]
With confirmed cases of coronavirus on the rise in the US, over 100,000 schools have closed, disrupting the education of over 55 million students. While many schools are […]
Starting March 30, 2020, with approval from the office of the Vice Chancellor for Research, the CITRIS Invention Lab and Jacobs Institute for Design Innovation […]
Wired: CITRIS Director Costas Spanos was recently featured in Wired for his work helping Singapore cut office energy use with the help of artificial intelligence. Read the story […]
COVID-19 Call for Proposals In the context of the Worldwide COVID-19 Pandemic, the C3.ai DTI is soliciting Research Award proposals that catalyze cooperative research activities […]
Sastry to co-direct, Spanos named chief scientist The University of California, Berkeley and the University of Illinois at Urbana-Champaign (UIUC) are the headquarters of a […]
CITRIS hosted its 4th Annual Women in Tech Symposium: Reimagining Cybersecurity for All on March 6 at UC Berkeley’s Sibley Auditorium. Focusing on inclusive cybersecurity, the symposium featured women leaders speaking on our shared cybersecurity future.
A CITRIS Foundry company, Correlia Biosystems represents the next generation of the life science industry. With their patented nanomaterial, they develop microscale tools to accelerate molecular interactions to measure proteins, thereby reducing the cost and time of drug development, clinical trials, and patient testing and monitoring.
